Fundraising FoxAvista — 2023 Investments
1 investments dated 2023 · listed companies and verified rows first · show all
RVL Pharmaceuticals develops prescription and skincare products for ocular and aesthetic care, including its flagship prescription eye drop Upneeq (oxymetazoline hydrochloride ophthalmic solution) and the Upneeq Reveal Under Eye Complex skincare product.
BiotechConsumerHealthtechBridgewater, US
Lori Deo(Chief Executive Officer)inRaymond Douglas(Head of Scientific Affairs)Amy Shah(Chief Growth Officer)inKaterina Gembarski(Chief Financial Officer)Kristin Comer(General Counsel)Jennifer Hanlon(Chief Marketing Officer)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.